| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/13/2001 | US6187802 Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use |
| 02/13/2001 | US6187801 6-chloro-2-methyl-8h-indeno(1,2-d)-thiazole hydrochloride, for example; administering to treat obesity, diabetes; anorectics |
| 02/13/2001 | US6187795 Methods and compositions for treating allergic disorders and other disorders using norastemizole in combination with other active ingredients |
| 02/13/2001 | US6187794 Administering as antiasthmatic agent; side effect reduction |
| 02/13/2001 | US6187778 4-aminopyrrole (3, 2-D) pyrimidines as neuropeptide Y receptor antagonists |
| 02/13/2001 | US6187777 Pyrrolo(3,2-d)pyrimidine derivatives; neuropeptide y and corticotropin releasing factor modulators; dietetics; antidiabetic, antiinflammatory, and antitumor agents |
| 02/13/2001 | US6187751 Biologically active peptide of ob protein |
| 02/13/2001 | US6187586 Nucleotide sequence of compound which inhibits expression of human serine/threonine kinase involved in signal transduction; diagnosis, prophylaxis, and therapy of related diseases |
| 02/13/2001 | US6187560 Nucleotide sequences coding mitochondrial polypeptide; for the treatment of dietetics, diabetes, hyperlipidemia and weight defects |
| 02/13/2001 | US6187545 Oligonucleotide sequences associated with the suppression of the activity of phosphenolpyruvate carboxykinase |
| 02/13/2001 | US6187314 Provide a more accurately defined ginkgo biloba extract by further identifying individual components of the flavonoid compounds, determining the amount of the individual components and regulating the ratio among them. |
| 02/08/2001 | WO2001055118A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient |
| 02/08/2001 | WO2001009612A1 Modulating binding site on potassium channels used for screening |
| 02/08/2001 | WO2001009379A1 Antisense modulation of pepck-mitochondrial expression |
| 02/08/2001 | WO2001009346A1 Gene encoding novel adenylate kinase 3 (ak3)-like protein |
| 02/08/2001 | WO2001009342A1 Microencapsulated nitric oxide synthase source |
| 02/08/2001 | WO2001009328A1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 02/08/2001 | WO2001009320A1 Gene encoding novel adp-ribosylation factor (arf)-like protein |
| 02/08/2001 | WO2001009184A1 Human g-protein coupled receptor |
| 02/08/2001 | WO2001009178A2 Human chaperone proteins |
| 02/08/2001 | WO2001009142A1 Oxazinocarbazoles for the treatment of cns diseases |
| 02/08/2001 | WO2001009138A2 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | WO2001009126A1 Serotonergic benzothiophenes |
| 02/08/2001 | WO2001009123A1 Benzofurylpiperazine serotonin agonists |
| 02/08/2001 | WO2001009122A2 Serotonergic benzofurans |
| 02/08/2001 | WO2001009121A2 2-pyrazolin-5-ones_as tyrosine kinase inhibitors |
| 02/08/2001 | WO2001009120A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 02/08/2001 | WO2001009116A2 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3- (4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)- 2-(4-METHOXYPHENYL)BENZO[b]THIOPHENE HYDROCHLORIDE |
| 02/08/2001 | WO2001009115A2 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3- (4-[2-(PIPERIDIN-1- YL)ETHOXY] PHENOXY)-2- (4-METHOXYPHENYL) BENZO[b]THIOPHENE HYDROCHLORIDE |
| 02/08/2001 | WO2001009111A1 Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists |
| 02/08/2001 | WO2001009110A1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 02/08/2001 | WO2001009106A1 Diamino-1,2,4-triazole-carboxylic and derivatives as gsk-3 inhibitors |
| 02/08/2001 | WO2001009097A1 Cyclic amine derivatives for the treatment of neurological diseases |
| 02/08/2001 | WO2001009090A2 Hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines |
| 02/08/2001 | WO2001008685A1 Acyclic and cyclic amine derivatives |
| 02/08/2001 | WO2001008680A1 Preparations for reducing oxygen consumption during physical efforts |
| 02/08/2001 | WO2001008673A1 Calcilytic compounds |
| 02/08/2001 | WO2001008657A2 Personal care articles |
| 02/08/2001 | WO2001008634A2 Polynucleotide encoding a human serine protease |
| 02/08/2001 | WO2001008505A2 Methods for suppressing appetite and enhancing exercise and recovery |
| 02/08/2001 | WO2000076984A3 Novel compounds, their use and preparation |
| 02/08/2001 | WO2000064485A8 Specifically targeted catalytic antagonists and uses thereof |
| 02/08/2001 | WO2000059851A8 Derivatives of venlafaxine and methods of preparing and using the same |
| 02/08/2001 | WO2000059525A3 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES |
| 02/08/2001 | WO2000058307A3 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands |
| 02/08/2001 | CA2391267A1 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | CA2380787A1 Microencapsulated nitric oxide synthase source |
| 02/08/2001 | CA2380644A1 2-pyrazolin-5-ones |
| 02/08/2001 | CA2380608A1 Serotonergic benzofurans |
| 02/08/2001 | CA2380531A1 Benzofurylpiperazine serotonin agonists |
| 02/08/2001 | CA2380489A1 Modulating binding site on potassium channels used for screening |
| 02/08/2001 | CA2380081A1 Calcilytic compounds |
| 02/08/2001 | CA2380032A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 02/08/2001 | CA2379993A1 Acyclic and cyclic amine derivatives |
| 02/08/2001 | CA2379538A1 Personal care articles |
| 02/08/2001 | CA2379360A1 Human g-protein coupled receptor |
| 02/08/2001 | CA2378929A1 Serine proteases |
| 02/08/2001 | CA2378879A1 Serotonergic benzothiophenes |
| 02/08/2001 | CA2378878A1 Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists |
| 02/08/2001 | CA2376927A1 Oxazinocarbazoles for the treatment of cns diseases |
| 02/08/2001 | CA2374743A1 Human chaperone proteins |
| 02/07/2001 | EP1074592A1 Process for preparing beadlets containing fat-soluble substances |
| 02/07/2001 | EP1074556A1 Phosphonic diester derivatives |
| 02/07/2001 | EP1074185A1 Incorporation of cholesterol lowering agents into confectionery dosage forms |
| 02/07/2001 | EP1073758A1 Retroviral vectors including modified envelope escort proteins |
| 02/07/2001 | EP1073694A1 Trans-xanthophyll ester concentrates of enhanced purity and methods of making same |
| 02/07/2001 | EP1073682A1 Heparanase specific molecular probes and their use in research and medical applications |
| 02/07/2001 | EP1073681A1 Cloning of a novel 7tm receptor axor-2 |
| 02/07/2001 | EP1073652A1 Paroxetine maleate |
| 02/07/2001 | EP1073639A1 Quinoline derivatives |
| 02/07/2001 | EP1073467A2 Cosolvent formulations |
| 02/07/2001 | EP1073466A1 Solution containing nicotine |
| 02/07/2001 | EP1073444A1 A food composition and method of using same |
| 02/07/2001 | EP1073424A1 Pellets having a core coated with a lipid lowering agent and a polymer |
| 02/07/2001 | CN1283196A N-pheny lamide and N-pyridylamide derivatives, method of preparing them and pharmaceutical compositions containing them |
| 02/07/2001 | CN1283116A Method of reducing craving in mamals |
| 02/07/2001 | CN1282599A Enqlish yew-manna tea |
| 02/07/2001 | CN1282595A Chinese medicine and its prescription for promoting blood circulation and reducing blood fat |
| 02/07/2001 | CN1282590A 三七胶囊 Thirty-seven Capsules |
| 02/07/2001 | CN1282581A Medicine composition |
| 02/07/2001 | CN1061653C Benzofuran compounds, process for their preparation and pharmaceutical compositions thereof |
| 02/07/2001 | CN1061562C Capsule for treating glycuresis |
| 02/07/2001 | CN1061560C 'Kangfuyidao Jiangtangdan' Chinese medicine for reducing blood sugar and recovering islets of pancreas and its preparation method |
| 02/06/2001 | US6184397 Preparation of sterol and stanol-esters |
| 02/06/2001 | US6184382 Process for preparing N6-substituted adenosine derivatives |
| 02/06/2001 | US6184352 Adseverin protein |
| 02/06/2001 | US6184237 Substituted pyridine compounds and methods of use |
| 02/06/2001 | US6184229 For treatment of disorders associated with the disfunctioning of nicotinic receptors |
| 02/06/2001 | US6184223 Reverse-turn mimetics and methods relating thereto |
| 02/06/2001 | US6184216 Effective both as antidiabetic agent and antiobesity agent |
| 02/06/2001 | US6184214 Hydrolysis of 2-dichlorophosphoryloxy-acrylonitrile to form 2-hydroxyacrylamide-o-monophosphate; antiischemic agents for treating disorders due to the lack of atp |
| 02/06/2001 | US6184209 Diabetes treatment |
| 02/06/2001 | US6184009 Process for the preparation of materials with a high content of conjugated long chain polyunsaturated fatty acids |
| 02/06/2001 | US6183993 Complement-resistant non-mammalian DNA viruses and uses thereof |
| 02/06/2001 | US6183775 Buccal delivery system |
| 02/06/2001 | US6183739 Phospholipases in animal feed |
| 02/06/2001 | CA2314798A1 1,2,4,5-tetrahydro-benzo[d]azepin derivatives |
| 02/06/2001 | CA2217768C Flavorful zinc compositions for oral use incorporating copper |
| 02/06/2001 | CA2106299C Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 02/01/2001 | WO2001007658A1 Abc transport polynucleotides, polypeptides, and antibodies |